C&R Research KRX:359090KOSDAQ

씨엔알리서치 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days1
DART filings, 7 days0
Articles tracked1since Sep 11

In Q2 2026, C&R Research reported revenue of ₩17.8bn, up 5.0% year on year, and operating profit of ₩176m. C&R Research (씨엔알리서치) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 1 article.

C&R Research quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩17.8bn+5.0%₩176m−₩136m
Q1 2026₩14.8bn-13.4%−₩974m−₩1.0bn
Q4 2025 derived₩15.2bn+7.1%₩93m−₩406m
Q3 2025₩15.8bn-4.0%₩246m₩547m
Q2 2025₩16.9bn+18.4%₩1.3bn₩1.2bn
Q1 2025₩17.0bn+15.7%−₩215m−₩354m
Q4 2024 derived₩14.2bn-9.7%−₩753m−₩19m
Q3 2024₩16.5bn+20.6%₩2.6bn₩2.0bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

C&R Research top stories 2 weeks, by number of outlets

  1. 1
    씨엔알리서치 차입금 반년새 2.3배…적자 자회사 확장에 자금 부담 커져
    1 outlets · 1 articlesFirst report Sep 14 06:45 메디코파마

Latest C&R Research news Korean headlines